Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New navigation and help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. The page now displays 'No longer looking for participants' to reflect recruitment status, and the revision tag changed from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:22:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5. This reflects a minor internal update to the page rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-06-08T04:22:41.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release or patch was applied. This appears to be an internal versioning update rather than a user-visible content change.
    Difference
    0.0%
    Check dated 2026-05-17T09:20:36.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    A revision/version label on the page footer was updated from v3.5.2 to v3.5.3, reflecting a technical software release rather than a change to the represented clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:46:53.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:39:54.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added Mucosa-associated lymphoma and B-cell chronic lymphocytic leukemia to the list of diseases relevant to the study.
    Difference
    0.1%
    Check dated 2026-03-28T03:26:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.